Results 271 to 280 of about 41,597 (297)
Some of the next articles are maybe not open access.
2015
Direct oral anticoagulants (DOACs) are rapidly changing the way we think about selecting, treating, and monitoring patients in need of anticoagulation. These agents may be used for either treatment or prophylaxis of systemic embolism and have been compared to vitamin K antagonist (e.g., warfarin) for many of the same indications.
openaire +1 more source
Direct oral anticoagulants (DOACs) are rapidly changing the way we think about selecting, treating, and monitoring patients in need of anticoagulation. These agents may be used for either treatment or prophylaxis of systemic embolism and have been compared to vitamin K antagonist (e.g., warfarin) for many of the same indications.
openaire +1 more source
Reversal of direct oral anticoagulants
British Journal of Hospital Medicine, 2018Oliver, Cohen +2 more
openaire +2 more sources
Direct oral anticoagulants and gastroenterologists
The Lancet Gastroenterology & Hepatology, 2017openaire +2 more sources
Direct oral anticoagulants: evidence and unresolved issues
Lancet, The, 2020Noel C Chan +2 more
exaly
Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study
Lupus, 2020A Undas, Anetta Undas
exaly